Compound coptis chinensis liquid
A technology of Coptis chinensis and compound recipes, applied in the field of compound Coptis chinensis liquid, can solve the problems of ineffectiveness of disease-resistant factors, reduced curative effect, and difficulty in obtaining it, and achieve the effects of easy storage and promotion, reduced production costs, and a wide range of applications
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Take 90g of Coptis chinensis, 30g of Scutellaria baicalensis, 30g of Cortex Phellodendri, 30g of Gardenia, 30g of Burnet, 30g of Rhubarb, and 30g of Astragalus.
[0021] Add 3L of water, extract at 100°C for 2 hours, filter out medicinal solution A for later use;
[0022] Take the dregs, add 2.5L of water, extract at 100°C for 2 hours, and filter out the medicinal solution B for later use;
[0023] Combine the medicinal liquids A and B, concentrate to a temperature of 80°C, and a relative density of 1.2. After cooling to room temperature, add 10 g of borneol and 5 L of ethanol, stir, let it stand, take the supernatant, recover the ethanol and add purified water to obtain 6 L of compound coptis liquid ;
[0024] Take the compound Coptis chinensis liquid, apply it to the affected area, and change the dressing every other day until the disease is cured.
Embodiment 2
[0026] Take Coptidis 95g, Scutellaria baicalensis 28g, Phellodendron 30g, Gardenia 28g, Burnet 30g, Rhubarb 32g, Astragalus 30g;
[0027] The preparation method is the same as in Example 1 to obtain compound Coptis chinensis liquid, which is used to wet compress the affected area.
Embodiment 3
[0029] Take Coptidis 88g, Scutellaria baicalensis 30g, Phellodendron 32g, Gardenia 28g, Burnet 32g, Rhubarb 32g, Astragalus 30g;
[0030] The preparation method is the same as in Example 1 to obtain compound Coptis chinensis liquid, which is used to wet compress the affected area.
[0031] In order to objectively evaluate the clinical effects of the present invention, from May, 1991 to May, 1995, chronic osteomyelitis cases were randomly divided into a compound coptis liquid external application group of the present invention (hereinafter referred to as a treatment group) and a gentamicin solution external application group (hereinafter referred to as a treatment group). called the control group). The curative effect of each group was evaluated according to the unified curative effect standard, and the results were as follows:
[0032] 1. Diagnostic criteria
[0033] (1) History of trauma infection, local soft tissue infection or acute hematogenous osteomyelitis;
[0034] (...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com